Prevalence of plasmid-mediated AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea

Microbial Drug Resistance

Volumn 12, Issue 1, 2006, Pages 44-49

  Lee, Kyungwon ^a   Lee, Miae ^b   Shin, Jong Hee ^c   Lee, Myung Hee ^d   Kang, Sung Ha ^e   Park, Ae Ja ^f   Yong, Dongeun ^a   Chong, Yunsop ^a,g  

^a Yonsei University   (South Korea)

^b Ewha Womans University   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d Seoul Veterans Hospital   (South Korea)

^e Hallym University   (South Korea)

^f Chung Ang University College of Medicine   (South Korea)

^g Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFOXITIN; CEFTRIAXONE; EXTENDED SPECTRUM BETA LACTAMASE;

ALLELE; AMPC GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BLA GENE; ESCHERICHIA COLI; GENE IDENTIFICATION; KLEBSIELLA OZAENAE; KLEBSIELLA PNEUMONIAE; KLEBSIELLA RHINOSCLEROMATIS; KOREA; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTPATIENT; PLASMID; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL;

BACTERIAL PROTEINS; BETA-LACTAMASES; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; KOREA; PLASMIDS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE SUBSP. OZAENAE; KLEBSIELLA PNEUMONIAE SUBSP. RHINOSCLEROMATIS;

EID: 33646075082     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2006.12.44     Document Type: Article

References (28)

1. Alvarez, M., J.H. Tran, N. Chow, and G.A. Jacoby. 2004. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob. Agents Chemother. 48:533-537.
2. Bauernfeind, A., Y. Chong, and K. Lee. 1998. Plasmid-encoded AmpC β-lactamases: how far have we gone 10 years after the discovery? Yonsei Med. J. 39:520-525.
3. Bauernfeind, A., Y. Chong, and S. Schweighart. 1989. Extended broad-spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17:316-321.
4. Bergquist P.L. 1998. Incompatibility. In K.G. Hardy (ed.), Plasmids, IRL Press, Oxford, pp. 37-78.
5. Bradford, P.A., C. Urban, R. Mariano, S.J. Projan, J.J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumonias is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569.
6. Coudron, P.E., N.B. Hanson, and M.W. Climo. 2003. Occurrence of extended-spectrum and AmpC β-lactamases in blood-stream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC β-lactamases. J. Clin. Microbiol. 41:772-777.
7. Farmer, J.J., III. 2003. Enterobacteriaceae: introduction and identification, In P.A. Murray, E.J. Baron, J.H. Jorgensen, M.A. Pfaller, and R.H. Yolken (ed.), Manual of clinical microbiology, 8th ed., American Society for Microbiology, Washington, DC, pp. 636-653.
8. Moyen, C.M., A.M. Hujer, K.M. Hujer, S.H. Marshall, L. Carias, P. Toltzis, L.B. Rice, and R.A. Bonomo. 2002. A clinical strain of Escherichia coli possessing CMY-2 plasmid-mediated AmpC β-lactamase: an emerging concern in pediatrics? Microb. Drug Resist. 8:329-333.
9. Jeong, S.H., I.K. Bae, J.H. Lee, S.G. Sohn, G.H. Kang, G.J. Jeon, Y.H. Kim, B.C. Jeong, and S.H. Lee. 2004. Molecular characterization of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean Nationwide Survey. J. Clin. Microbiol. 42:2902-2906.
10. Kim, J., Y. Kwon, H. Pai, J.-W. Kim, and D.-T. Cho. 1998. Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J. Clin. Microbiol. 36:1446-1449.
11. Kim, J.-Y., Y.-J. Park, S.-O. Lee, W. Song, S.H. Jeong, Y.A. Yoo, and K.-Y. Lee. 2004. Bacteremia due to Salmonella enterica serotype Montevideo producing plasmid-mediated AmpC β-lactamase (DHA-1). Ann. Clin. Lab. Sci. 34:214-217.
12. Kim, J.Y., J.S. Song, S.H. Bak, Y.E. Cho, D.W. Kim, S.H. Jeong, Y.M. Park, K.J. Lee, and S.H. Lee. 2004. Dissemination of Escherichia coli producing AmpC-type β-lactamase (CMY-11) in Korea. Int. J. Antimicrob. Agents 24:320-326.
13. CMY-10 a novel, plasmid-encoded AmpC-type β-lactamase gene in a clinical isolate of Enterobacter aerogenes. J. Appl. Microbiol. 95:744-752.
14. Lee, J.H., H.I. Jung, J.H. Jung, J.S. Park, J.B. Ahn, S.H. Jeong, B.C. Jeong, J.H. Lee, and S.H. Lee. 2004. Dissemination of transferable AmpC-type β-lactamase (CMY-10) in a Korean hospital. Microb. Drug Resist. 10:224-230.
15. CMY-11, an AmpC-type plasmid-mediated β-lactamase gene in a Korean clinical isolate of Escherichia coli. J. Antimicrob. Chemother. 49:269-273.
16. Lee, K., Y.A. Kim, Y.J. Park, H.S. Lee, M.Y. Kim, E.-C. Kim D. Yong, Y. Chong, and Korean Nationwide Surveillance of Antimicrobial Resistance Group. 2004. Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroquinolone-resistant gram-negative bacilli: a KONSAR study in 2002. Yonsei Med. J. 45:598-608.
17. Lee, K., D. Yong, J.H. Yum, Y.S. Lim, H.S. Kim, B.K. Lee, and Y. Chong. 2004. Emergence of multidrug-resistant Salmonella enterica serovar Typhi in Korea. Antimicrob. Agents Chemother. 48:4130-4135.
18. Moland, E.S., J.A. Black, J. Ourada, M.D. Reisbig, N.B. Hanson, and K.S. Thomson. 2002. Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob. Agents Chemother. 46:3837-3842.
19. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing; Supplement M100-S13. National Committee for Clinical Laboratory Standards. Wayne, PA.
20. Papanicolaou, G.A., A.A. Medeiros, and G.A. Jacoby. 1990. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34:2200-2209.
21. Perez-Perez, F.J., and N.D. Hanson. 2002. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
22. Philippen, A., G. Arlet, and G.A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
23. Pitout, J.D.D., M.D. Reisbig, E.C. Venter, D.L. Church, and N.D. Hanson. 2003. Modification of the double-disk test for detection of Enterobacteriaceae producing extended-spectrum and AmpC β-lactamases. J. Clin. Microbiol. 41:3933-3935.
24. Poirel, L., C. Héritier, C. Spicq, and P. Nordmann. 2004. In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J. Clin. Microbiol. 42:3831-3833.
25. Song, W., J.-S. Kim, M.-N. Kim, E.-J. Kim, Y.-J. Park, D. Yong, K. Lee, and W.G. Lee. 2002. Occurrence and genotypic distribution of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Korea. Korean J. Lab. Med. 22:410-418.
26. Winokur, P.L., R. Canton, J.-M. Casellas, and N. Legakis. 2001. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific Region. Clin. Infect. Dis. 32:S94-S103.
27. CMY-2 among E. coli isolates from food animals, retail ground meats, and humans in Southern Taiwan. Antimicrob. Agents Chemother. 48:1353-1356.
28. Yan, J.-J., W.-C. Ko, H.-M. Wu, S.-H. Tsai, C.-L. Chuang, and J.-J. Wu. 2004. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan. J. Clin. Microbiol. 42:5337-5340.